Name and surname:
|
doc. MUDr. Ema Kantorová, PhD.
|
Document type:
|
Research/art/teacher profile of a person
|
The name of the university:
|
Comenius University Bratislava
|
The seat of the university:
|
Šafárikovo námestie 6, 818 06 Bratislava
|
III.a - Occupation-position | III.b - Institution | III.c - Duration |
---|---|---|
lecturer | Medical Faculty, Palacky University in Olomouc, Czech Republic | 1995-1999 |
resident neurologist | University Hospital in Martin, Slovakia | 2000-2007 |
licenced neurologist + researcher | University Hospital in Martin + Jessenius Faculty of Medicine | 1.9.2007 - 31.8.2012 |
licenced neurologist + lecturer | University Hospital in Martin, Jessenius Faculty of Medicine | 1.9.2012 - 31.5.2018 |
associate professor | Jessenius Faculty of Medicine | 1.6.2018 - present |
IV.a - Activity description, course name, other | IV.b - Name of the institution | IV.c - Year |
---|---|---|
Electroencephalography I. | Jessenius Faculty of Medicine in Martin | 2020 |
V.1.a - Name of the profile course | V.1.b - Study programme | V.1.c - Degree | V.1.d - Field of study |
---|---|---|---|
Neurology | General Medicine | I., II. | General Medicine |
Neurology and Nursing | Nursing | I., II. | Nursing |
Internal Medicine/Gerontology and Nursing | Nursing | I., II. | Nursing |
V.2.a - Name of the study programme | V.2.b - Degree | V.2.c - Field of study |
---|---|---|
Neurology - specialization training | II. | Neurology |
V.3.a - Name of the field of habilitation procedure and inaugural procedure | V.3.b - Study field to which it is assigned |
---|---|
Neurology | General medicine |
V.5.a - Name of the course | V.5.b - Study programme | V.5.c - Degree | V.5.d - Field of study |
---|---|---|---|
Seminary of Diploma Thesis | General Medicine | I | General Medicine |
Tolebrutinib Phase 2b Study Group [Autorská korporácia] ; Reich, Daniel S. - Arnold, Douglas L. -Vermersch, Patrick (Autor) - Bar-Or, Amit - Fox, Robert J. - Matta, Andre - Turner, Timothy - Wallström, Erik- Zhang, Xinyan - Mareš, Miroslav - Khabirov, Farit A. - Traboulsee, Anthony - Kantorová, Ema (Člen korporácie):
Safety and efficacy of tolebrutinib, an oral brain-penetrant BTK inhibitor, in relapsing multiple sclerosis: a phase 2b, randomised, double-blind, placebo-controlled trial. DOI10.1016/S1474-4422(21)00237-4. – In: The Lancet Neurology : Lancet Publishing Group. – ISSN 1474-4422. – ISSN 1474-4465. – Roč. 20, č. 9 (2021), s. 729-738.
IF: 59.935 - 2021, SNIP: 15,324 - 2021, SJR: 11,67 - 2021, CiteScore: 54,2 - 2021, AIS: 16.564 - 2021. Kvartil Q (2021): AIS - Clinical neurology - Q1 JIF - Clinical neurology - Q1 Scimago - Neurology(clinical) - Q1. Ohlasy (101)
Hečková, Eva - Dal-Bianco, Assunta - Strasser, Bernhard - Hangel, Gilbert J - Lipka, Alexandra - Motyka, Stanislav - Hingerl, Lukas - Rommer, Paulus - Berger, Thomas - Hnilicová, Petra - Kantorová, Ema - Leutmezer, Fritz - Kurča, Egon - Gruber, Stephan - Trattnig, Siegfried - Bogner, Wolfgang:
Extensive Brain Pathologic Alterations Detected with 7.0-T MR Spectroscopic Imaging Associated with Disability in Multiple Sclerosis. DOI 10.1148/radiol.210614. In: Radiology: Radiological society of North America. –ISSN 0033-8419. – ISSN 1527-1315. – Roč. 303, č. 1 (2022), s. 141-150.
IF (2022) = 19.7, SNIP: 4,222 - 2022, SJR: 4,073 - 2022, CiteScore: 34,2 - 2022, AIS: 3.740 - 2022. Kvartil Q (2022): AIS - Radiology, nuclear medicine & medical imaging - Q1 JCI - Radiology, nuclear medicine & medical imaging - Q1 JIF - Radiology, nuclear medicine & medical imaging - Q1 Scimago- Radiology, nuclear medicine and imaging - Q1. Ohlasy (16)
Lipka, A - Niess, E - Dal-Bianco, A - Hangel, G - Rommer, P - Strasser, B - Motyka, S - Hingerl,L - Berger, Th- Hnilicová, P - Kantorová, E - Leutmezer, F - Kurča, E - Gruber, S - Trattnig, S - Bogner, W:
Lesion-Specific Metabolic Alterations in Relapsing-Remitting Multiple Sclerosis Via 7 T Magnetic Resonance Spectroscopic Imaging.In: Investigative radiology [elektronický dokument]. - Roč. 58, č. 2 (2023), s. 156-165 . - ISSN 0020-9996.
IF (JCR) 2023 = 7.0, Q1: Radiology, nuclear medicine and medical imaging, wos-jcr. Ohlasy (2).
Kantorová, E- Hnilicová, P- Bogner, W- Grendár, M- Čierny, D- Hečková, E - Strasser, B- Ružinák, R, Zeleňák,K - Kurča, E:
Positivity of oligoclonal bands in the cerebrospinal fluid predisposed to metabolic changes and rearrangement of inhibitory/excitatory neurotransmitters in subcortical brain structures inmultiple sclerosis. In: Multiple Sclerosis and Related Disorders. - Roč. 52 (2021), s. [1-7], ISSN 2211-0348.
IF (JCR) 2021 = 4.808, Q2: AIS Clinical neurology, Q2: JIF Clinical neurology, Q2: Scimago Medicine (miscellanous), Q1: Scimago Neurology, Q2: Scimago Neurology clinical, wos-jcr. Ohlasy (4)
Kantorová E, Vítková M, Martiníková M, Cimprichová A, Fedičová M, Kováčová S, Mako M, Cisár J, Hančinová V, Szilasiová J, Koleda P, Roháľová J, Polóniová J, Karlík M, Slezáková D, Klímová E, Maciak M, Kurča E, Hnilicová P.
Identification of alemtuzumab-suitable multiple sclerosis patients in Slovakia and sequencing of post-alemtuzumab immunomodulatory treatment. Ther Adv Neurol Disord. 2024 Oct28;17:17562864241285556. doi: 10.1177/17562864241285556.
IF 4,7 - 2023. Q1 - AIS Clinical neurology 2023, Q1 - JCI Clinical neurology 2023, Q1 - JIF Clinical neurology 2023
Tolebrutinib Phase 2b Study Group [Autorská korporácia] ; Reich, Daniel S. - Arnold, Douglas L. -Vermersch, Patrick (Autor) - Bar-Or, Amit - Fox, Robert J. - Matta, Andre - Turner, Timothy - Wallström, Erik- Zhang, Xinyan - Mareš, Miroslav - Khabirov, Farit A. - Traboulsee, Anthony - Kantorová, Ema (Člen korporácie):
Safety and efficacy of tolebrutinib, an oral brain-penetrant BTK inhibitor, in relapsing multiple sclerosis: a phase 2b, randomised, double-blind, placebo-controlled trial. DOI10.1016/S1474-4422(21)00237-4. – In: The Lancet Neurology : Lancet Publishing Group. – ISSN 1474-4422. – ISSN 1474-4465. – Roč. 20, č. 9 (2021), s. 729-738.
IF: 59.935 - 2021, SNIP: 15,324 - 2021, SJR: 11,67 - 2021, CiteScore: 54,2 - 2021, AIS: 16.564 - 2021. Kvartil Q (2021): AIS - Clinical neurology - Q1 JIF - Clinical neurology - Q1 Scimago - Neurology(clinical) - Q1. Ohlasy (101)
Hečková, Eva - Dal-Bianco, Assunta - Strasser, Bernhard - Hangel, Gilbert J - Lipka, Alexandra - Motyka, Stanislav - Hingerl, Lukas - Rommer, Paulus - Berger, Thomas - Hnilicová, Petra - Kantorová, Ema - Leutmezer, Fritz - Kurča, Egon - Gruber, Stephan - Trattnig, Siegfried - Bogner, Wolfgang:
Extensive Brain Pathologic Alterations Detected with 7.0-T MR Spectroscopic Imaging Associated with Disability in Multiple Sclerosis. DOI 10.1148/radiol.210614. In: Radiology: Radiological society of North America. –ISSN 0033-8419. – ISSN 1527-1315. – Roč. 303, č. 1 (2022), s. 141-150.
IF (2022) = 19.7, SNIP: 4,222 - 2022, SJR: 4,073 - 2022, CiteScore: 34,2 - 2022, AIS: 3.740 - 2022. Kvartil Q (2022): AIS - Radiology, nuclear medicine & medical imaging - Q1 JCI - Radiology, nuclear medicine & medical imaging - Q1 JIF - Radiology, nuclear medicine & medical imaging - Q1 Scimago- Radiology, nuclear medicine and imaging - Q1. Ohlasy (16)
Lipka, A - Niess, E - Dal-Bianco, A - Hangel, G - Rommer, P - Strasser, B - Motyka, S - Hingerl,L - Berger, Th- Hnilicová, P - Kantorová, E - Leutmezer, F - Kurča, E - Gruber, S - Trattnig, S - Bogner, W:
Lesion-Specific Metabolic Alterations in Relapsing-Remitting Multiple Sclerosis Via 7 T Magnetic Resonance Spectroscopic Imaging.In: Investigative radiology [elektronický dokument]. - Roč. 58, č. 2 (2023), s. 156-165 . - ISSN 0020-9996.
IF (JCR) 2023 = 7.0, Q1: Radiology, nuclear medicine and medical imaging, wos-jcr. Ohlasy (2).
Kantorová, E- Hnilicová, P- Bogner, W- Grendár, M- Čierny, D- Hečková, E - Strasser, B- Ružinák, RZeleňák,
K - Kurča, E:
Positivity of oligoclonal bands in the cerebrospinal fluid predisposed to metabolic changes and rearrangement of inhibitory/excitatory neurotransmitters in subcortical brain structures inmultiple sclerosis. In: Multiple Sclerosis and Related Disorders. - Roč. 52 (2021), s. [1-7], ISSN 2211-0348.
IF (JCR) 2021 = 4.808, Q2: AIS Clinical neurology, Q2: JIF Clinical neurology, Q2: Scimago Medicine (miscellanous), Q1: Scimago Neurology, Q2: Scimago Neurology clinical, wos-jcr. Ohlasy (4)
Kantorová E, Vítková M, Martiníková M, Cimprichová A, Fedičová M, Kováčová S, Mako M, Cisár J, Hančinová V, Szilasiová J, Koleda P, Roháľová J, Polóniová J, Karlík M, Slezáková D, Klímová E, Maciak M, Kurča E, Hnilicová P.
Identification of alemtuzumab-suitable multiple sclerosis patients in Slovakia and sequencing of post-alemtuzumab immunomodulatory treatment. Ther Adv Neurol Disord. 2024 Oct28;17:17562864241285556. doi: 10.1177/17562864241285556.
IF 4,7 - 2023. Q1 - AIS Clinical neurology 2023, Q1 - JCI Clinical neurology 2023, Q1 - JIF Clinical neurology 2023
Kantorová, E - Poláček, H - Bittšanský, M - Baranovičová, E- Hnilicová, P - Čierny, D - Sivák, Š - Nosáľ,V - Zeleňák, K - Kurča, E: Hypothalamic damage in multiple sclerosis correlates with disease activity, disability, depression, and fatigue. In: Neurological Research. - Roč. 39, č. 4 (2017), s. 323-330. - ISSN 0161-6412, IF (JCR) 2017=1.449, Q4: jcr-sjr. Citations (36).
Hečková, E - Dal-Bianco, A - Strasser, B - Hangel, G - Lipka, A - Motyka, S- Hingerl, L - Rommer, P - Berger, Th - Hnilicová, P- Kantorová, E - Leutmezer, F - Kurča, E - Gruber, S - Trattnig, S - Bogner,W: Extensive Brain Pathologic Alterations Detected with 7.0-T MR Spectroscopic Imaging Associated with Disability in Multiple Sclerosis.In: Radiology. - Roč. 303, č. 1 (2022), s. 141-150 . - ISSN 0033-8419. IF (JCR) 2021=29.146, Q1:wos-jcr. Citations (9)
Cited in: [n1] 2022 zz ~ Barker, P. B.: Radiology, roč. 303, č. 1, 2022, s. 151-152. IF (JCR) 2021=29.146, Q1:wos-jcr
Hečková, E - Dal-Bianco, A - Strasser, B - Hangel, G - Lipka, A - Motyka, S- Hingerl, L - Rommer, P - Berger, Th - Hnilicová, P- Kantorová, E - Leutmezer, F - Kurča, E - Gruber, S - Trattnig, S - Bogner,W: Extensive Brain Pathologic Alterations Detected with 7.0-T MR Spectroscopic Imaging Associated with Disability in Multiple Sclerosis.In: Radiology. - Roč. 303, č. 1 (2022), s. 141-150. - ISSN 0033-8419. IF (JCR) 2021=29.146, Q1:wos-jcr. Citations (9)
Cited in: [n1] Wright, A. M. - Murali-Manohar, S. - Henning, A.: NeuroImage, č. 263, 2022, čl. č. 119574. IF (2022) = 7.4, Q1:wos-jcr
Kantorová, E - Poláček, H - Bittšanský, M - Baranovičová, E- Hnilicová, P - Čierny, D - Sivák, Š - Nosáľ,V - Zeleňák, K - Kurča, E: Hypothalamic damage in multiple sclerosis correlates with disease activity, disability, depression, and fatigue. In: Neurological Research. - Roč. 39, č. 4 (2017), s. 323-330. ISSN 0161-6412, IF (JCR) 2017=1.449, Q2: jcr-sjr. Citations (36).
Hečková, E - Dal-Bianco, A - Strasser, B - Hangel, G - Lipka, A - Motyka, S- Hingerl, L - Rommer, P - Berger, Th - Hnilicová, P- Kantorová, E - Leutmezer, F - Kurča, E - Gruber, S - Trattnig, S - Bogner,W: Extensive Brain Pathologic Alterations Detected with 7.0-T MR Spectroscopic Imaging Associated with Disability in Multiple Sclerosis.In: Radiology. - Roč. 303, č. 1 (2022), s. 141-150. - ISSN 0033-8419. IF (JCR) 2021=29.146, Q1:wos-jcr. Citations (9)
Cited in: [n1] 2023 zz ~ van der Weijden, C. W. J. - Biondetti, E. - Gutmann, I. W. - Dijkstra, H. - McKerchar, R. - Faria, D. D. - de Vries, E. F. J. - Meilof, J. F. - Dierckx, R. A. J. O. - Prevost, V. H. - Rauscher, A.: Quantitative myelin imaging with MRI and PET: an overview of techniques and their validation status. In: Brain, roč. 146, č. 4, 2023, s. 1243-1266. IF (2023) 14.5, Q1: sci-scopus
APVV-14- 0088 Multiparametric mapping of brain tissue using magnetic resonance in selected neuroloical disorders (Investigator) 01.10.2013 - 30.09.2017
In: Trending Topics in Multiple Sclerosis. - Rijeka : InTech, 2016. - S. 195-210 [1,2AH]. - ISBN 978-
953- 51-2656-0
(Principal investigation) 2016-2018
VEGA 1/0301/19 Assessment of cognitive impairment in multiple sclerosis and its relationship with genetic and radiological markers, 1/2019-12/2022 (Principal investigator)
Hnilicová, P - Štrbák, O - Kolísek, M - Kurča, E - Zeleňák, K - Sivák, Š - Kantorová, E: Current Methods of Magnetic Resonance for Noninvasive Assessment of Molecular Aspects of Pathoetiology in Multiple Sclerosis. In: International journal of molecular sciences. - Roč. 21, č. 17 (2020), s. [1-34], art. no. 6117 ISSN 1422-0067. IF (JCR) 2020=5.924, Q1:wos-jcr. Citations (4)
• Kantorová, E- Hnilicová, P- Bogner, W- Grendár, M- Čierny, D- Hečková, E - Strasser, BRužinák, R- Zeleňák, K - Kurča, E: Positivity of oligoclonal bands in the cerebrospinal fluid predisposed to metabolic changes and rearrangement of inhibitory/excitatory neurotransmitters in subcortical brain structures inmultiple sclerosis. In: Multiple Sclerosis and Related Disorders. - Roč. 52 (2021), s. [1-7], ISSN 2211-0348.
IF (JCR) 2020=4.339, Q2: wos-jcr. Citations (4)
• Kantorová, E - Hnilicová, P - Bogner, W - Grendár, M) - Grossmann, J - Kováčová, S - Hečková, E - Strasser, B - Čierny, D - Zeleňák, K - Kurča, E: Neurocognitive performance in relapsing-remitting multiple sclerosis patientsis associated with metabolic abnormalities of the thalamus but not the hippocampus- GABA-edited 1H MRS study. In: Neurological Research. - Roč. 44, č. 1 (2022), s. 57-64 - ISSN 0161-6412. IF (JCR) 2021=2.529, Q2:wos-jcr. Citations (2)
Projekt VEGA č. 1/0092/22, „Využitie nadštandardných rádiologických, proteomických a genetických analýz pri diferenciálnej diagnostike progresívnych foriem sklerózy multiplex“ zástupca vedúceho projektu, hlavný riešiteľ od r 2024
Project APVV 22-0065: Pokročilá diagnostika neurodegeneratívnych ochorení pomocou techník magnetickej rezonancie a umelej inteligencie. Advanced diagnostics of neurodegenerative disorders using magnetic resonance techniques and artificial intelligence.
(2023 - ). Subinvestigator
VII.a - Activity, position | VII.b - Name of the institution, board | VII.c - Duration |
---|---|---|
Member of the Editorial Board | Neurológia | 2018 - present |
Member of the Scientific Panel of Neuroimmunology | European Academy of Neurology | 2022 - |
organisation staff member | Neurological congresses | 2011- present |
VIII.a - Name of the institution | VIII.b - Address of the institution | VIII.c - Duration (indicate the duration of stay) | VIII.d - Mobility scheme, employment contract, other (describe) |
---|---|---|---|
Medical University of Vienna, High Field MR Centre | Lazarettgasse 14 1090 Vienna, Austria | Examination of patients, financed by VEGA 1/0287/16 |